Thyroid cancer, nonmedullary, 2
- Synonyms
- THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO; Thyroid carcinoma, follicular, somatic
Summary
Available tests
Clinical tests (104 available)
Genes See tests for all associated and related genes
Also known as: C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras, HRAS
Summary: HRas proto-oncogene, GTPaseAlso known as: HIPER1, MINPP2, MIPP, PCH16, MINPP1
Summary: multiple inositol-polyphosphate phosphatase 1Also known as: ALPS4, CMNS, KRAS, N-ras, NCMS, NRAS1, NS6, NRAS
Summary: NRAS proto-oncogene, GTPaseAlso known as: ARHGAP13, NMTC2, SRGAP1
Summary: SLIT-ROBO Rho GTPase activating protein 1
Clinical features
Help- Neoplasm
- Familial nonmedullary thyroid carcinoma
Familial nonmedullary thyroid carcinoma
- MedGen UID: 502247
- Concept ID: C3501843
- Finding: Neoplastic Process
Neoplasm
- Follicular thyroid carcinoma
Follicular thyroid carcinoma
- MedGen UID: 64630
- Concept ID: C0206682
- Finding: Neoplastic Process
Neoplasm
- Papillary thyroid carcinoma
Papillary thyroid carcinoma
- MedGen UID: 66773
- Concept ID: C0238463
- Finding: Neoplastic Process
Neoplasm
- Familial nonmedullary thyroid carcinoma
- NICE, 2022UK NICE Guideline NG230, Thyroid cancer: assessment and management
- AHRQ, 2013Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.